Collectively, the results suggest that the upregulated activity of the AKT pathway, de novo lipogenesis, and glycolysis altogether resulted in metabolic disturbances, which facilitated the development of NAFLD/NASH-driven HCC in WT mice. This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatotic liver disease.